Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT

被引:316
作者
Papadopoulou, Anastasia [1 ]
Gerdemann, Ulrike [1 ]
Katari, Usha L. [1 ]
Tzannou, Ifigenia [1 ]
Liu, Hao [1 ]
Martinez, Caridad [1 ]
Leung, Kathryn [1 ]
Carrum, George [1 ]
Gee, Adrian P. [1 ]
Vera, Juan F. [1 ]
Krance, Robert A. [1 ]
Brenner, Malcolm K. [1 ]
Rooney, Cliona M. [1 ]
Heslop, Helen E. [1 ]
Leen, Ann M. [1 ]
机构
[1] Texas Childrens Hosp, Baylor Coll Med, Houston Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
关键词
EPSTEIN-BARR-VIRUS; HUMAN-HERPESVIRUS; 6; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; ADOPTIVE TRANSFER; VIRAL-INFECTIONS; TRANSPLANT RECIPIENTS; PROPHYLACTIC INFUSION; HEMORRHAGIC CYSTITIS; CLINICAL-FEATURES; IMMUNE-RESPONSES;
D O I
10.1126/scitranslmed.3008825
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It remains difficult to treat the multiplicity of distinct viral infections that afflict immunocompromised patients. Adoptive transfer of virus-specific T cells (VSTs) can be safe and effective, but such cells have been complex to prepare and limited in antiviral range. We now demonstrate the feasibility and clinical utility of rapidly generated single-culture VSTs that recognize 12 immunogenic antigens from five viruses (Epstein-Barr virus, adenovirus, cytomegalovirus, BK virus, and human herpesvirus 6) that frequently cause disease in immunocompromised patients. When administered to 11 recipients of allogeneic transplants, 8 of whom had up to four active infections with the targeted viruses, these VSTs proved safe in all subjects and produced an overall 94% virological and clinical response rate that was sustained long-term.
引用
收藏
页数:11
相关论文
共 59 条
[1]  
ASANO Y, 1994, PEDIATRICS, V93, P104
[2]   Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient [J].
Balduzzi, A. ;
Lucchini, G. ;
Hirsch, H. H. ;
Basso, S. ;
Cioni, M. ;
Rovelli, A. ;
Zincone, A. ;
Grimaldi, M. ;
Corti, P. ;
Bonanomi, S. ;
Biondi, A. ;
Locatelli, F. ;
Biagi, E. ;
Comoli, P. .
BONE MARROW TRANSPLANTATION, 2011, 46 (07) :987-992
[3]   Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes [J].
Barker, Juliet N. ;
Doubrovina, Ekaterina ;
Sauter, Craig ;
Jaroscak, Jennifer J. ;
Perales, Miguel A. ;
Doubrovin, Mikhail ;
Prockop, Susan E. ;
Koehne, Guenther ;
O'Reilly, Richard J. .
BLOOD, 2010, 116 (23) :5045-5049
[4]   Human Herpesvirus 6 Infection after Hematopoietic Cell Transplantation: Is Routine Surveillance Necessary? [J].
Betts, Brian C. ;
Young, Jo-Anne H. ;
Ustun, Celalettin ;
Cao, Qing ;
Weisdorf, Daniel J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (10) :1562-1568
[5]   Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation [J].
Blyth, Emily ;
Clancy, Leighton ;
Simms, Renee ;
Ma, Chun K. K. ;
Burgess, Jane ;
Deo, Shivashni ;
Byth, Karen ;
Dubosq, Ming-Celine ;
Shaw, Peter J. ;
Micklethwaite, Kenneth P. ;
Gottlieb, David J. .
BLOOD, 2013, 121 (18) :3745-3758
[6]   BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses [J].
Blyth, Emily ;
Clancy, Leighton ;
Simms, Renee ;
Gaundar, Shivashni ;
O'Connell, Philip ;
Micklethwaite, Kenneth ;
Gottlieb, David J. .
TRANSPLANTATION, 2011, 92 (10) :1077-1084
[7]   Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial [J].
Brentjens, Renier ;
Yeh, Raymond ;
Bernal, Yvette ;
Riviere, Isabelle ;
Sadelain, Michel .
MOLECULAR THERAPY, 2010, 18 (04) :666-668
[8]   New response criteria for lymphomas in clinical trials [J].
Cheson, B. D. .
ANNALS OF ONCOLOGY, 2008, 19 :35-38
[9]   Cellular immune responses to BK virus [J].
Comoli, Patrizia ;
Hirsch, Hans H. ;
Ginevri, Fabrizio .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2008, 13 (06) :569-574
[10]   Update on human herpesvirus 6 biology, clinical features, and therapy [J].
De Bolle, L ;
Naesens, L ;
De Clercq, E .
CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (01) :217-+